Details

Autor(en) / Beteiligte

• Le Gal, Grégoire
• Kovacs, Michael J
• Bertoletti, Laurent
• Couturaud, Francis
• Dennie, Carole
• Hirsch, Andrew M
• Huisman, Menno V
• Klok, Frederikus A
• Kraaijpoel, Noémie
• Mallick, Ranjeeta
• Pecarskie, Amanda
• Pena, Elena
• Phillips, Penny
• Pichon, Isabelle
• Ramsay, Tim
• Righini, Marc
• Rodger, Marc A
• Roy, Pierre-Marie
• Sanchez, Olivier
• Schmidt, Jeannot
• Schulman, Sam
• Shivakumar, Sudeep
• Trinh-Duc, Albert
• Verdet, Rachel
• Vinsonneau, Ulric
• Wells, Philip
• Wu, Cynthia
• Yeo, Erik
• Carrier, Marc

Titel

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study

Ist Teil von

• Annals of internal medicine, 2022-01, Vol.175 (1), p.29

Ort / Verlag

United States

Erscheinungsjahr

2022

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• The incidence of pulmonary embolism has been increasing, but its case-fatality rate is decreasing, suggesting a lesser severity of illness. The clinical importance of patients with pulmonary embolism isolated to the subsegmental vessels is unknown. To determine the rate of recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation. Multicenter prospective cohort study. (ClinicalTrials.gov: NCT01455818). Eighteen sites between February 2011 and February 2021. Patients with isolated subsegmental pulmonary embolism. At diagnosis, patients underwent bilateral lower-extremity venous ultrasonography, which was repeated 1 week later if results were negative. Patients without deep venous thrombosis did not receive anticoagulant therapy. The primary outcome was recurrent venous thromboembolism during the 90-day follow-up period. Recruitment was stopped prematurely because the predefined stopping rule was met after 292 of a projected 300 patients were enrolled. Of the 266 patients included in the primary analysis, the primary outcome occurred in 8 patients, for a cumulative incidence of 3.1% (95% CI, 1.6% to 6.1%) over the 90-day follow-up. The incidence of recurrent venous thromboembolism was 2.1% (CI, 0.8% to 5.5%) and 5.7% (CI, 2.2% to 14.4%) over the 90-day follow-up in patients with single and multiple isolated subsegmental pulmonary embolism, respectively. No patients had a fatal recurrent pulmonary embolism. The study was restricted to patients with low-risk subsegmental pulmonary embolism. Overall, patients with subsegmental pulmonary embolism who did not have proximal deep venous thrombosis had a higher-than-expected rate of recurrent venous thromboembolism. Heart and Stroke Foundation of Canada and French Ministry of Health Programme Hospitalier de Recherche Clinique.